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The potential benefits of addressing nicotine addiction as part of substance dependency
treatment may include improved response to interventions for other addictions and, over
the long term, reduced tobacco-related morbidity and mortality. The authors recount the
experiences of three inpatient programs that instituted nicotine addiction interventions 
and a tobacco-free policy for both facilities and patients. After making adjustments to
counter temporary adverse effects of the policy, two of the programs are achieving higher
overall treatment completion rates than prior to implementation. Outstanding research
issues include quantifying the costs and benefits of the antinicotine interventions, determin-
ing the long-term impact of tobacco-free treatment, and tailoring treatment to various
patient groups.
P
roviders of treatment for alcohol and other drug dependencies have been
slow to address nicotine dependence (Abrams, 1995; Ellingstad et al., 1999),
even though an estimated 80 to 95 percent of people addicted to alcohol are smok-
ers (Patten et al., 1996). Moreover, alcohol-dependent smokers are more likely
to die from tobacco-related causes than from diseases associated with other
drug or alcohol consumption (Hurt et al., 1993). 
The conventional wisdom has been, “Let’s not make them quit everything
at once” (notably, tobacco seems to be the only addictive substance given such an
exemption). Treatment professionals have expressed concerns that the stress of
quitting smoking might jeopardize patients’ recovery from other addictions (Bobo
et al., 1995), and patients themselves often believe that smoking cessation will
threaten their sobriety (Monti et al., 1995). There has been little research, how-
ever, to validate these fears, and at least one study found no adverse effects of con-
currently treating alcoholism and nicotine dependence (Hurt et al., 1994). There
is even some evidence that smoking cessation reduces the risk of alcohol relapse
(Sobell et al., 1995). In other studies, smokers who abused opiates or cocaine were
found to have a harder time with abstinence from illegal drugs than did non-
smokers, and nicotine craving increased their cravings for other drugs (Frosch et
al., 2000; Taylor et al., 2000). While research tends to allay fears that taking
action against nicotine addiction will compromise
other drug abuse treatments, programs have also been
concerned that such interventions might have high
economic costs. The potential considerations are: 
• Loss of market share (if the number of referrals
decreases or patients choose other programs where
they would be allowed to continue smoking);
• Reductions in patient completion rates (if patients
are discharged for violations of smoking rules or
drop out of the program against clinical advice);
• Expenses for nicotine replacement medications and
monitoring equipment; and
• Increased staff turnover (if smokers on staff prefer
to leave the smoke-free environment).
This article recounts the experiences of three
inpatient chemical dependency programs that recently
began treating nicotine dependence along with the
other addictions and that have converted to tobacco-
free. Consistent with the approach to other drugs, the
programs forbid patients and staff from having tobacco
products on their premises and test patients to deter-
mine whether they have smoked while out on pass.
An inpatient treatment period is a particularly
opportune time to address nicotine addiction because
people addicted to alcohol and other drugs tend to
be heavier smokers than people who do not have other
drug dependencies (Monti et al., 1995). Inpatient
treatment has been found superior to outpatient treat-
ment for smokers who are moderately to severely nico-
tine dependent (Hays et al., 2001). Of course, fol-
lowing discharge, outpatient treatment of nicotine
addiction is necessary for continuity of care.
GOING TOBACCO-FREE
The ATC Programs
New York State’s Office of Alcoholism and Substance
Abuse Services (OASAS) operates 13 Addiction
Treatment Centers. All treat adults who are depend-
ent on chemicals and meet the criteria for inpatient
care (for example, they have failed to remain absti-
nent with outpatient treatment or they are homeless).
As State-operated facilities, the ATCs are charged with
providing inpatient treatment of addictions for all
who need it, regardless of their ability to pay. 
Among ATC patients statewide, 83 percent
are unemployed, 50 percent are homeless, 40 percent
are involved with the criminal justice system, 66 per-
cent have a co-occurring mental health diagnosis, and
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83 percent abuse more than one substance in addi-
tion to tobacco. The patient population is 79 percent
male, the average age 37. The average length of stay
in an ATC is 25 days, and nearly three-quarters of
admitted patients, 73 percent, complete their course
of treatment and move on to other levels of care in
the community.
Three of the ATCs have established tobacco-free
programs: Stutzman ATC in Buffalo, Norris ATC in
Rochester, and Dick Van Dyke ATC in Ovid.  The
Norris and Van Dyke ATCs established their nicotine
treatment programs October 1, 1996. Stutzman ATC
followed in August 1998. Each of the programs entered
its “contemplation stage” several years before taking
action for real change. The preparation period began
1 year prior to implementation. 
Getting Started
While the arguments in favor of integrating nicotine
dependence treatment into the addictions treatment
setting are both research-based and perfectly logi-
cal, staff, allied health and human service provider
agencies, and patients may react in ways ranging from
mild surprise to active resistance. It is therefore nec-
essary to plan the change carefully and invest sub-
stantial preparation time with all stakeholders, to
address and negotiate real and imagined concerns such
as those mentioned above.
Throughout their preparation processes the ATCs
followed guidelines provided by Slade and Hoffman
(1992; see “Steps to Becoming a Tobacco-Free Treatment
Facility”). Rustin (1998) reports that programs that
did not follow such a process were unsuccessful in
their efforts to become tobacco-free.
Two of the ATCs conducted a survey of staff atti-
tudes toward nicotine dependence at the beginning
of the transition process (see “Survey of Staff Knowledge
and Beliefs Regarding Nicotine Dependency Treatment”).
These ATCs had already been moving toward treat-
ing this addiction for years, and the survey results
overwhelmingly favored this course. At the third ATC,
Stutzman, the staff had reached consensus on the need
to go tobacco-free some time previously, so the sur-
vey was deemed unnecessary.
Although the programs worked hard to prepare
patients prior to the changeover date, problems began
immediately. Instead of patients turning in all tobacco
products and paraphernalia as agreed, contraband was
widespread and the smell of smoke remained. Patients
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out on pass.1.  Do you believe that nicotine is:
❍  An addictive drug that is more addictive than other drugs 
of dependence.
❍  An addictive drug that is just as addictive as other drugs 
of dependence.
❍  An addictive drug, but not as addictive as other drugs of 
dependence.
❍  A drug, but not addictive.
❍  Not a drug.
2.  How important is the treatment of nicotine dependence in
a patient’s overall medical health?
❍  Extremely important.
❍  Very important.
❍  Somewhat important.
❍  Not at all important.
3.  How will nicotine dependence treatment (tobacco absti-
nence) affect a patient’s overall recovery?
❍ It is essential for healthy recovery.
❍ It will help the patient’s recovery a lot.
❍ It may help the patient’s overall recovery a little bit.
❍ It will not have any effect (neither help nor harm) on over-
all recovery.
❍  It will harm a patient’s overall recovery.
4.  Do you think that treating nicotine dependence along with
other addictions is a good idea?
❍ Absolutely; a drug is a drug is a drug!
❍ Yes, but we need to allow patients to choose their own 
time-line for stopping their tobacco use.
❍  Maybe; we need to examine this matter on a case-by-case 
basis.
❍  No. Nicotine dependence has no relevance to other 
addictions.
❍ Definitely not! Addressing nicotine dependence while a 
patient is in treatment for other addictions is damaging to
patient care.
Survey of Staff Knowledge and Beliefs Regarding Nicotine Dependency Treatment
5.  What kind of support for staff will be needed to create a 
tobacco-free facility?
6.  What training and/or information would you like to have 
regarding nicotine dependence?  (Mark all that apply.)
❍  The basics: An understanding of the nature of nicotine 
dependence.
❍  Nicotine treatment and recovery, including withdrawal 
management.
❍  Medical aspects of tobacco use.
❍  How nicotine use relates to other chemical use.
❍  Psychosocial and cultural aspects of nicotine use.
❍  Marketing and advertising factors.
❍  Informal discussion exploring our beliefs regarding 
tobacco use.
❍  Other:
7. What is your personal relationship to nicotine?
❍ Never used.
❍ Tried, but never regular use.
❍ Former user.
❍ Current user.
❍ No comment.
8. Other  comments?
Directors of the Norris and Van Dyke ATCs used this survey with their staffs to determine the likelihood of opposition to a tobacco-
free policy, needs for education about nicotine addiction, needs for assistance with smoking cessation by clinic personnel, and
expectations for training in treatment of nicotine dependence. The survey findings informed their plans for transition to a tobacco-
free treatment program and facilities.
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contraband materials and smoke than staff did to catch
them. 
This poor initial response had roots in an admin-
istrative decision. Because the tobacco-free policy was
new, the ATCs had decided to follow a “three-
infraction rule.” The first violation of the tobacco-
free policy resulted in a warning, the second in a case
conference and a change in the patient’s treatment
plan, and the third in the patient’s discharge. This
practice proved disastrous. Patients took the three-
infraction rule as license to use tobacco products until
they were caught twice. Consequently, a large amount
of contraband was maintained in the facilities, and
numerous infractions consumed a great deal of staff
time.
Two key changes set the programs on a better
track. First, 18 months after the changeover, the first
two facilities instituted “zero tolerance” for violations
of the tobacco-free policy. Stutzman ATC instituted
“zero tolerance” in only 6 weeks. This made program
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practices consistent across all drugs and sent an unam-
biguous message to the patients. Second, each pro-
gram procured a carbon monoxide (CO) monitor.
With the monitor, staff members could make viola-
tors accountable without having to actually catch
them smoking or find contraband on their person.
Current Practices
All prospective patients are asked to sign a “Tobacco-
Free Contract” at admission. The contract reviews the
rationale for treating nicotine dependence in con-
junction with other addictions and outlines both sur-
veillance measures (testing and searches) and the con-
sequence for violation of the contract—discharge
from the facility. A thorough chemical dependency
history is taken at admission, and if nicotine depend-
ence is diagnosed, the treatment team and the patient
together generate a treatment plan. 
Patients who meet the DSM-IV criteria for nico-
tine dependence—some 80 to 90 percent at admis-
sion—receive an offer of nicotine replacement ther-
apy (NRT) with the transdermal patch. Counselors
educate patients individually about NRT, which is
particularly important because many patients are
unaware of NRT or have formed negative impressions
of it. For example, some patients have heard that
the patch can cause a heart attack, which is incorrect.
Others have heard that it causes nightmares and rashes,
both of which do happen to some patients, but are
generally minor inconveniences. Still other patients
believe the patch will not relieve their nicotine crav-
ings, or that they shouldn’t use a “crutch” to quit smok-
ing. Some patients choose to quit “cold turkey.”
If a patient accepts NRT, the treatment team
engages the patient in a discussion focusing on the
appropriate dose and duration of patch use. The physi-
cian orders and the nursing staff administers a patch
to the patient at the beginning of the medical inter-
view, along with detailed instructions for using the
patch and information about common side effects.
Minor side effects can be treated with over-the-counter
preparations and usually are not severe enough to war-
rant discontinuation of patch use. Fewer than 
10 percent of the patients who have tried the nico-
tine patch at the ATCs have stopped using it because
of side effects. Patients who cannot tolerate the patch’s
side effects are offered nicotine gum. Some ATC
patients receive Zyban (bupropion) as an alterna-
tive or in addition to NRT.
Steps to Becoming a Tobacco-Free Treatment Facility 
1.  Acknowledge the challenges tobacco creates for the addictions treat-
ment community.
2. Establish a leadership committee of nicotine-free representatives of  
each staff level.
3. Develop a tobacco-free policy.
4. Establish a timeline for implementing the policy with measurable goals 
and objectives.
5. Provide training for the staff.
6. Provide assistance with recovery for nicotine-dependent staff members.
7. Assess and diagnose nicotine-dependent patients and use this informa-
tion in treatment planning.
8. Incorporate nicotine dependence and cessation into the patient educa-
tion curriculum.
9. Establish ongoing communication with 12-step recovery groups, 
professional colleagues, and referral sources about policy changes.
10. Require that no staff member be identifiable as a tobacco user.
11. Establish a tobacco-free facility and grounds.
12. Implement comprehensive treatment for nicotine dependence 
throughout the program.
Adapted from Slade, J., and Hoffman, A.L. (1992). Addressing Tobacco in the
Treatment of Other Addictions: Steps for Becoming Tobacco-Free. Addressing Tobacco
in the Treatment of Other Addictions Project: New Brunswick, NJ.
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The initial dosage of the nicotine patch is matched
to the number of cigarettes smoked per day. Heavy
smokers (one and one-half to three packs per day)
receive a high dose, up to two 21-mg patches per day,
which has been shown to be safe and to more ade-
quately relieve withdrawal symptoms in this spe-
cific group of smokers (Dale et al., 1995). Combination
NRT, using the patch reinforced by nicotine gum as
needed to treat excess cravings, has also been used suc-
cessfully with virtually no increase in side effects
(Kornitzer et al., 1995). 
The programs have integrated nicotine addic-
tion intervention into all their treatment activities,
including individual and group therapy. Counselors
are encouraged to substitute the phrase “tobacco, alco-
hol, and other drugs” for such terms as “chemicals”
or “alcohol and drugs.”nicotine support groups are
incorporated into the program schedule.
Generally, the counseling skills used to treat other
drug dependencies apply directly to nicotine addic-
tion. When we train the staffs of community addic-
tion agencies, the counselors are relieved to learn that
they already possess the skills needed to treat nicotine
dependence. Moreover, counselors can use nicotine
addiction as a very useful prototype for teaching about
all addictions. For example, most of our patients do
not experience strong cravings for drugs other than
nicotine while in treatment, partly because of the
absence of many triggers in the treatment setting.
Cravings for nicotine, on the other hand, tend to be
quite prevalent, especially in the first few days fol-
lowing cessation of the drug. These cravings pro-
vide a ready opportunity to teach patients coping
strategies, which they can then use to avoid or resist
cravings for any drug. In this and other ways, inte-
grating treatment for nicotine dependence may enhance
counselors’ overall effectiveness in treating chemical
dependence.
Tobacco products, like alcohol and other drugs,
are banned from the grounds of the ATCs. Tobacco
paraphernalia, such as lighters or matches, are con-
sidered contraband and their possession is grounds
for discharge. The staff is not permitted to show
any evidence of tobacco use while at work. Visitors
and family members are not permitted to use or pos-
sess tobacco products while on facility property.
The ATCs use a carbon monoxide monitor to
test patients for tobacco use. These devices can detect
elevated CO levels in the breath for up to several hours
after a person has smoked. Similar to the process for
breathalyzer and urine toxicology testing, patients are
tested on admission, on return from outside passes,
and randomly while they are in residence. Use of
tobacco products is treated as relapse and is handled
like relapse to use of alcohol or other drugs, with dis-
charge as a necessary measure.
The programs take administrative discharge very
seriously and review their discharge policy and records
frequently. The overriding priority has been to main-
tain the integrity of a tobacco-, alcohol-, and drug-
free setting for treatment. Unfortunately, we have
learned from experience that any leniency or ambi-
guity regarding the use of any substance, including
tobacco, tends to result in a dramatic increase in the
use of chemicals on the unit that typically entraps the
most vulnerable patients into relapse. When a patient
is discharged administratively, the program makes
every effort to facilitate continued treatment with
another provider. 
Patients are tapered from NRT according to indi-
vidual needs. Some request a weekly taper, while oth-
ers are able to totally stop nicotine replacement
after a few days in controlled tobacco-free settings
with none of the usual smoking cues. Still others will
request longer periods of treatment, or even an increased
dose to respond to increased withdrawal symptoms
or high-risk situations where they may be exposed to
greater temptations or opportunities to smoke.
Once a patient has completed treatment, he or
she is offered opportunities for continued NRT as
needed. The continued use of NRT is individualized
and not necessarily indicative of the patient’s treat-
ment progress or lack of progress. Efforts are made to
offer every patient continued counseling for nicotine
addiction, and the ATCs’ outreach actions have resulted
in such counseling becoming more available in the
community. In New York State, Medicaid covers
the cost of nicotine patches and nicotine gum if the
patient has a prescription. 
IMPACT ON PROGRAM COSTS
Market Share
The impact of going tobacco-free on market share
was remarkably slight for all three ATCs. Annual refer-
rals have remained the same or increased. Referral
agencies have indicated that no more than 5 percent
of their clients refused to consider admission to a facil-
ity where they could not smoke. An increasing minor-
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ity of admitted patients are saying that the tobacco-
free policy was a plus in their decision to go to the
ATCs.
Program Census and Completion Rates
The ATCs’ criteria for completion of treatment are
abstinence from tobacco, alcohol, and other drugs;
attainment of all or most inpatient treatment goals;
and completion of a plan for continued care. In all
three ATCs, the tobacco-free policy initially had a
dramatic negative impact on the portion of patients
achieving these objectives, but the dip proved to be
brief. One program’s monthly completion rate plum-
meted from 75 percent to below 50 percent, but recov-
ered to 70 percent within 4 months. The resulting
effect on the average census was ameliorated some-
what by increasing the number of admissions to fill
the beds vacated by patients who either left against
clinical advice or were discharged for using tobacco
products while in treatment.
Rates of completion and average daily census
have returned to the levels reported prior to going
tobacco-free and now remain at those levels or higher.
The Stutzman ATC discharged 2 percent of its patients
for smoking violations before it went tobacco-free,
and it is currently discharging patients at the same
rate. The Van Dyke ATC had a completion rate of 
70 percent prior to going tobacco-free, and its cur-
rent completion rate is over 80 percent. This improve-
ment is most likely due to the ATCs’ overall contin-
uous performance improvement efforts. The Norris
ATC’s completion rate is about 65 percent, slightly
lower than the rate prior to institution of the tobacco-
free policy.
Expenditures
NRT can be expensive for providers. The annual expen-
diture for nicotine patches for the three ATCs, which
have a combined total of 107 beds, is $82,000. This
translates to approximately $766 per bed or $51 per
admission. In addition, CO monitors cost nearly
$1,000 apiece, and a supply of disposable mouth-
pieces must be maintained.
Prior to going tobacco-free, however, the ATCs
were spending nearly half as much on NRT for patients
who were attempting to stop smoking. Those efforts
often failed because of social pressures from smoking
patients. The additional costs for implementing the
full tobacco-free program amount to less than 2 per-
cent of the ATCs’ budget, and would be far less in
agencies that receive reimbursement from Medicaid
and other third-party payers. With a success rate greater
than 95 percent for getting patients to quit smok-
ing during addiction treatment, the expenditure seems
well worth the outcome in projected reduced health
care costs and patient mortality. Furthermore, being
tobacco-free reduces fire hazards and decreases expen-
ditures for cleaning and painting.
Staff Turnover
All three ATCs were fortunate to have few smokers
on staff when the project started. Consequently, the
conversion to being tobacco-free did not cause any
staff turnover. Those few smokers on staff prior to the
changeover decided to quit smoking. For facilities
with a greater number of active smokers among the
staff, the preparation phase might have to be drawn
out and more supports provided to assist employees
in becoming tobacco-free.
CLINICAL RECOMMENDATIONS 
Attention to treating nicotine dependence is finally
coming to the fore in the treatment community. Our
experiences at the OASAS ATCs demonstrate that
transition to tobacco-free chemical dependency treat-
ment is manageable. Addiction professionals already
have the expertise to treat many forms of psychoac-
tive dependence and this is easily transferable to the
treatment of nicotine dependence. We recommend
the following steps:
• Read the research literature on nicotine. Copious
research findings on addressing nicotine depen-
dence in the last 10 years can reduce many of the
fears expressed by program managers and profes-
sionals. Among the pioneers in the field are Richard
Hurt, M.D., and Terry Rustin, M.D. Dr. Hurt has
integrated nicotine treatment into inpatient addic-
tion treatment at the Mayo Clinic. Dr. Rustin has
assisted several addiction programs to become
tobacco-free. He is the author of Quit and Stay Quit:
A Personal Program to Stop Smoking, and his Web
site (www.quitandstayquit.com) includes many
resources for addiction programs.
• Follow a planned process.Too often programs have
rushed into becoming tobacco-free only to subse-
quently retreat in the face of stubborn opposition
from staff, patients, or the community. Detailed
guides include Slade and Hoffman (1992) and Drug-
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Free Is Nicotine-Free: A Manual for Chemical
Dependency Treatment Programs (Hoffman et al.,
1997). It is especially important that treatment
providers not institute a policy forbidding tobacco
use without providing support for patients’ and staff
members’ cessation efforts.
RESEARCH RECOMMENDATIONS 
• Develop “best practice” benchmarks for reducing
costs and quantifying the benefits of transition.
The more the real transition costs can be reduced,
the more likely programs will become tobacco-free.
How can we determine the effective dosage of NRT
for individual clients? How can we measure the
short- and long-term effects of tobacco cessation
on reduction of health care costs and on mortality
rates?
• Determine the long-term impact of tobacco-free
treatment on the recovery and general health of
patients. Followup surveys from one of the ATCs
documented that as many as 12 percent of former
smokers stayed tobacco-free for the first 3 months
after discharge. Are these cessation rates sustained
over time? Can they be improved with continued
treatment for tobacco dependence in outpatient
settings?
• Tailor treatment to subtypes of patients. Does
tobacco-free chemical dependency treatment need
to be adjusted for various groups of patients—for
example, women, who typically are less successful
than men with NRT, or patients with co-occurring
psychiatric disorders?
CONCLUSION
The chemical dependency field has been slow to inte-
grate treatment for nicotine dependence for fear that
such an intervention might undermine recovery from
addiction to alcohol and other drugs. There is grow-
ing evidence that including nicotine treatment in
chemical dependency programs may enhance treat-
ment outcomes; many other studies have failed to
document any negative effects. The experience 
of three inpatient treatment programs that converted
to being tobacco-free indicates only temporary 
adverse effects while providing an additional, poten-
tially long-term treatment benefit for patients. Research
is needed to find ways of reducing the costs and quan-
tifying the benefits of becoming tobacco-free. 
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